Zobrazeno 1 - 10
of 812
pro vyhledávání: '"Avril, M.-F"'
Autor:
McArthur, G.A. *, Maio, M., Arance, A., Nathan, P., Blank, C., Avril, M.-F., Garbe, C., Hauschild, A., Schadendorf, D., Hamid, O., Fluck, M., Thebeau, M., Schachter, J., Kefford, R., Chamberlain, M., Makrutzki, M., Robson, S., Gonzalez, R., Margolin, K.
Publikováno v:
In Annals of Oncology March 2017 28(3):634-641
Autor:
Bohelay, G., Kluger, N., Battistella, M., Biaggi-Frassati, A., Plantier, F., Harraudeau, A., Avril, M.-F., Pedeutour, F., Fraitag, S.
Publikováno v:
In Annales de dermatologie et de venereologie October 2015 142(10):541-548
Autor:
Avril, M.-F., Bahadoran, P., Cabaret, O., Caron, O., de la Fouchardière, A., Demenais, F., Desjardins, L., Frébourg, T., Hammel, P., Leccia, M.-T., Lesueur, F., Mahé, E., Martin, L., Maubec, E., Remenieras, A., Richard, S., Robert, C., Soufir, N., Stoppa-Lyonnet, D., Thomas, L., Vabres, P., Bressac- de Paillerets, B.
Publikováno v:
In Annales de dermatologie et de venereologie January 2015 142(1):26-36
Autor:
Qasmi, S., Sutra-Loubet, C., Maubec, E., Boitier, F., Duvillard, P., Carlotti, A., Marinho, E., Jacobelli, S., Franck, N., Gorin, I., Vacher-Lavenu, M.-C., Bouscarat, F., Crickx, B., Dupin, N., Avril, M.-F.
Publikováno v:
In Annales de dermatologie et de venereologie 2010 137(12):769-774
Autor:
Kramkimel, N., Maubec, E., Boitier, F., Cavalcanti, A., Beldi, M., Mamelle, G., Kolb, F., Duvillard, P., Avril, M.-F.
Publikováno v:
In Annales de dermatologie et de venereologie 2010 137(4):276-280
Publikováno v:
In Annales de dermatologie et de venereologie 2009 136(2):214-219
Publikováno v:
Cancer Causes & Control, 1992 May 01. 3(3), 199-205.
Externí odkaz:
https://www.jstor.org/stable/3553232
Autor:
Bottomley, A., Coens, C., Mierzynska, J., Blank, C. U., Mandalà, M., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A. M., Meshcheryakov, A., Khattak, A., Carlino, M. S., Sandhu, S., Puig, S., Ascierto, P. A., Larkin, J., Lorigan, P. C., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M., van den Eertwegh, A. J. M., Grob, J. -J., Gutzmer, R., Jamal, R., van Akkooi, A. C. J., Krepler, C., Ibrahim, N., Marreaud, S., Kicinski, M., Suciu, S., Robert, C., Eggermont, A. M. M., EORTC Melanoma Group, Lesimple, T., Maio, M., Linette, G., Mortier, L., Svane, I. M., Schachter, J., Brown, M., Hersey, P., Barrow, C., Kudchadkar, R., Dutriaux, C., Song, X., Quaglino, P., Queirolo, P., Meier, F., Stroyakovskiy, D., Guillot, B., Romero, P. L. O., Bastholt, L., Garbe, C., Grange, F., Mohr, P., Algazi, A., Bechter, O., Hernberg, M., Loquai, C., Meiss, F., Chiarion Sileni, V., Bar-Sela, G., Fitzharris, B., Saiag, P., Arnault, J. -P., Simon, J. -C., Stephens, R., Baurain, J. -F., Lebbe, C., Combemale, P., Dummer, R., Hauschild, A., Parente, P., Yamazaki, N., Milhem, M., Leccia, M. -T., Geoffrois, L., Kretschmer, L., Dunwoodie, E., Walker, J., Lotem, M., Hendler, D., Mackiewicz, A., Sekulovic, L., Dzienis, M., Hospers, G. A. P., Siano, M., Hassel, J., Corrie, P., Passos, M. -J., Levin, M., Hoeller, C., Machet, L., Hallmeyer, S., Waterston, A., Descamps, V., Kiecker, F., Aarts, M., Schmidt, H., Raimundo, A., Nyakas, M., Lacour, J. -P., Berking, C., Ferrucci, P. F., Jameson, M., Kim, K., Yokota, K., Kerger, J., Aubin, F., Groenewegen, G., Kapiteijn, H., Boehncke, W. -H., Utikal, J., Casasola, R., Marshall, E., Ferraresi, V., Richtig, E., Matkovic, S., Inozume, T., Crook, T., Mcneil, C., Kiyohara, Y., Avril, M. -F., Hein, R., Terheyden, P., Nathan, P., Aoi, J., Skytta, T., Jouary, T., Takenouchi, T., Straume, O., Martins, C., Mukhametshina, G.
Publikováno v:
Lancet. Oncology, Vol. 22, No 5 (2021) pp. 655-664
EORTC Melanoma Group 2021, ' Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial ', The Lancet Oncology, vol. 22, no. 5, pp. 655-664 . https://doi.org/10.1016/S1470-2045(21)00081-4
Lancet Oncology, 22, 5, pp. 655-664
The Lancet Oncology, 22(5), 655-664. Lancet Publishing Group
Lancet Oncology, 22, 655-664
Lancet Oncology
Lancet Oncology, 2021, 22 (5), pp.655-664. ⟨10.1016/S1470-2045(21)00081-4⟩
The Lancet Oncology, 22(5), 655-664. ELSEVIER SCIENCE INC
EORTC Melanoma Group 2021, ' Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial ', The Lancet Oncology, vol. 22, no. 5, pp. 655-664 . https://doi.org/10.1016/S1470-2045(21)00081-4
Lancet Oncology, 22, 5, pp. 655-664
The Lancet Oncology, 22(5), 655-664. Lancet Publishing Group
Lancet Oncology, 22, 655-664
Lancet Oncology
Lancet Oncology, 2021, 22 (5), pp.655-664. ⟨10.1016/S1470-2045(21)00081-4⟩
The Lancet Oncology, 22(5), 655-664. ELSEVIER SCIENCE INC
Background: The European Organisation for Research and Treatment of Cancer (EORTC) 1325-MG/KEYNOTE-054 trial in patients with resected, high-risk stage III melanoma demonstrated improved recurrence-free survival with adjuvant pembrolizumab compared w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80dc0ff7069bff303dade337b8effb2d
https://archive-ouverte.unige.ch/unige:159804
https://archive-ouverte.unige.ch/unige:159804
Epidemiologic studies have reported inconsistent results regarding an association between Parkinson disease (PD) and cutaneous melanoma (melanoma). Identifying shared genetic architecture between these diseases can support epidemiologic findings and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::1905f5887039213174d4ef010ad945b1
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3189403
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3189403
Most genetic susceptibility to cutaneous melanoma remains to be discovered. Meta-analysis genome-wide association study (GWAS) of 36,760 cases of melanoma (67% newly genotyped) and 375,188 controls identified 54 significant (P < 5 × 10−8) loci wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::f9497572df9165ff7b18fe8fd7541be8
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077491
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077491